THIS MONTH’S ISSUE

Read, save, and print articles from the current issue

ARTICLES

Chronological index
2013–2017

PRODUCT GUIDES

Compare all instruments
and software systems

DEPARTMENTS

Chronological index
2013–2017

MARKETPLACE

New pathology lab products and industry news

Home » Archive by Tags

Articles tagged with: Siemens Healthineers‎

Siemens, Fast-track Diagnostics deal, 10/17

October 2017—Siemens Healthineers announced a strategic relationship with Fast-track Diagnostics that includes the addition of FTD’s broad range of CE-marked kits and multisyndromic panels to the menu of Siemens’ Versant kPCR Molecular System.

FDA-cleared Atellica Solution, 9/17

September 2017—Siemens Healthineers showcased its Atellica Solution, flexible, scalable, automation-ready immunoassay and chemistry analyzers for laboratory diagnostics, at the 69th AACC Annual Scientific Meeting and Clinical Lab Expo. The 510(k)-cleared Atellica Solution, for mid- and high-volume labs, comprises sample management and immunoassay and chemistry analyzer components.

Siemens buys Epocal from Alere, 8/17

August 2017—Siemens Healthineers has entered into a definitive agreement to acquire Epocal, a subsidiary of Alere. Epocal develops and provides point-of-care blood diagnostic systems for health care enterprises, including the epoc Blood Analysis System, a handheld, wireless testing solution.

Siemens buys Epocal from Alere

July 26, 2017—Siemens Healthineers has entered into a definitive agreement to acquire Epocal, a subsidiary of Alere. Epocal develops and …

Siemens, Fast-track Diagnostics deal

June 23, 2017—In an effort to provide customers with expanded, more comprehensive solutions for molecular testing, Siemens Healthineers announced a …

Siemens and Relaymed deal

June 14, 2017—Siemens Healthineers announced a strategic alliance with Relaymed to bring customers secure, cloud-based connectivity for Siemens…

Siemens gets $8.9 million to develop Zika test, 6/17

June 2017—The U.S. Department of Health and Human Services announced that Siemens Healthineers has been awarded $8.9 million by the Office of the Assistant Secretary for Preparedness and Response’s Biomedical Advanced Research and Development Authority to advance the development of a Zika assay for use on the company’s Advia Centaur XPT, Advia Centaur XP, and Advia Centaur CP immunoassay systems for the clinical laboratory.

High-throughput immunoassay system

May 4, 2017—Siemens Healthineers Advia Centaur XPT Immunoassay System offers a comprehensive infectious disease testing menu for laboratory…

Siemens’ HCV genotype test receives PMA

April 11, 2017—The Food and Drug Administration has granted premarket approval for the Versant HCV Genotype 2.0 Assay (LiPA) from …

FDA-cleared POC coagulation analyzer, 11/16

November 2016—Siemens Healthineers received FDA 510(k) clearance for its Xprecia Stride Coagulation Analyzer, a handheld, portable coagulation analyzer designed to deliver fast, reliable prothrombin time international normalized ratio testing for point-of-care monitoring and management of oral anticoagulation therapy with warfarin.

X